LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities ...

When the parts of the ear that transmit sound to the auditory nerve are damaged—as they often are in the severely deaf—a hearing aid that merely amplifies sound offers little assistance. Today, more ...

Cochlear Ltd. and Sensorion SA have published encouraging results on the combination of a molecule with a cochlear implant. Their proof-of-concept phase 2a study involved the combination of an orphan ...

The dividend maths on this fallen ASX healthcare heavyweight. The post How many Cochlear shares do I need to buy for $10,000 ...

Thank you for standing by, and welcome to the Cochlear Limited Half Year 2025 Results Analyst and Media Briefing. All participants are in listen-only mode. There will be presentation, followed by a ...

The market is focused on the problems, but I think the decade-long opportunity still looks attractive. The post Here's why ...

Thank you for standing by, and welcome to the Cochlear Limited FY '25 Results Analyst and Media Briefing. [Operator Instructions] I would now like to hand the conference over to Mr. Dig Howitt, CEO ...